• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsZeo Scientifix
    Picture of Zeo Scientifix logo

    ZEOX — Zeo Scientifix Share News

    $1.440.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    • Market Cap
      $11.29m
    • Enterprise Value
      $9.78m
    • Revenue
      $5.20m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ZEOX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ZEOX Dividends
    • Brief: Organicell Regenerative Says Zofin Therapy Approved By Pakistani Regulators To Be Used For A Covid-19 Patient On Compassionate Grounds

      11/05/2021 12:51
    • Brief: Organicell Begins Up-Listing Process On Nasdaq

      04/05/2021 13:11
    • Brief: Organicell Announces Positive Results Of Initial Covid-19 Zofin™ Patient Trial In India And Trial Expansion

      28/04/2021 12:59
    • Brief: Organicell Completes Enrollment For Its Expanded Access Trial To Treat Covid-19 Patients With Zofin™

      22/04/2021 12:38
    • Brief: Organicell Announces FDA Approval Of IND Application For Use Of Zofin In The Treatment Of Chronic Obstructive Pulmonary Disease

      28/01/2021 12:38
    • Brief: Organicell Says FDA Granted Expanded Access To Treat COVID-19 Patients With Zofin

      29/09/2020 12:28
    • Brief: Organicell Regenerative Medicine - FDA Granted Emergency, Expanded Access Approval To Treat 2 Mild To Moderate Covid-19 Patients

      02/09/2020 12:06
    • Brief: Organicell Announces FDA Approval Of Ind Application For The Treatment Of Sars Due To Covid-19

      05/05/2020 14:06

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.